





Netflix shares are down 22% YTD and trade at the lowest valuation since 2022, ahead of Q2 earnings on July 16. Q1 revenue rose 16.2% YoY to $12.2B and EPS jumped 86% to $1.23, helped by a $2.8B Warner Bros. Discovery termination fee, but the Q2 outlook calls for $12.57B revenue (+13.5%). Despite concerns over engagement metrics (including potential live-TV experiments), the article argues valuation is supportive (24x earnings, 23x forward) and notes analysts’ median target of $115 (+56% upside).
The market is treating this as a maturity problem, not a growth problem: if engagement is flattening, the multiple should compress even with solid FCF. Adding live programming is best read as a retention defense, which can support ad inventory and reduce churn, but it also signals that incremental hours are becoming more expensive to manufacture. That is constructive for scale players with balance-sheet flexibility and a headwind for smaller streamers that would have to fund similar experiments with weaker cash generation.
Near term, the July 16 print is the real catalyst, not the product rumor. A clean beat may lift the stock for a few sessions, but the bigger question is whether management can show that engagement softness is isolated rather than a structural ceiling on price increases and ad-tier monetization. If guidance does not reaccelerate, the market may keep NFLX in a low-to-mid-20s earnings multiple despite strong absolute FCF.
The contrarian miss is that cheap versus history is not cheap versus the likely growth regime. If live TV becomes a real initiative, content rights holders gain negotiating leverage and margin expansion may slow, which matters more to the next 12 months than headline revenue growth. WBD is less a direct beneficiary than a relative-value short: any streamer needing more content spend while carrying leverage is more vulnerable if Netflix chooses to defend engagement aggressively.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment